Ignite Creation Date:
2024-05-06 @ 2:36 AM
Last Modification Date:
2024-10-26 @ 11:20 AM
Study NCT ID:
NCT02080156
Status:
UNKNOWN
Last Update Posted:
2015-06-24
First Post:
2014-02-22
Brief Title:
Impact of Continuous Positive Airway Pressure CPAP Therapy on Outcomes in Patients Undergoing Coronary Revascularization
Sponsor:
Beijing Anzhen Hospital
Organization:
Beijing Anzhen Hospital
Study Overview
Official Title:
Impact of Continuous Positive Airway Pressure Therapy on Outcomes in Patients Undergoing Coronary Revascularization
Status:
UNKNOWN
Status Verified Date:
2015-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigators assume that continuous positive airway pressure CPAP therapy can reduce the mortality stroke rate and secondary coronary surgery in CAD with obstructive sleep apnea OSA patients after percutaneous coronary intervention PCI or coronary artery bypass grafting CABA during postoperative follow-up of 3 years
Detailed Description:
Investigators observe whether continuous positive airway pressure CPAP therapy can reduce the mortality stroke rate and secondary coronary surgery in CAD with OSA patients after percutaneous coronary intervention PCI or coronary artery bypass grafting CABA during postoperative follow-up of 3 years During the 3 years we randomize all enrolled patients to 2 groups separately beginning CPAP or no-CPAP intervention after sleep monitoring Guidance for all patients during follow-up 1 week 2 week 1 month 3 month The follow-up procedure includes clinical assessments at three months six months one year two and three years respectivelyThe primary outcome variables are prospectively being documented and are not subject to observer biasBaseline comorbidity data results of the sleep recordings compliance with CPAP device scores of the questionnaires as well as results of the blood analysis are performed andor documented consecutively in separate files by research personnel blinded to the allocation of the study groups andor unaware of the results of the concomitant outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None